Feasibility of Romiplostim Discontinuation in Adult Thrombopoietin-Receptor Agonist Responsive Patients with Primary Immune Thrombocytopenia: An Observational Retrospective Report in Real Life Clinical Practice

Thrombopoietin mimetics are new treatment options for patients with immune throm-bocytopenia (ITP). Because of their mechanism of action, long-term administration was envisioned in order to maintain effective thrombopoiesis. We report on 30 romiplostim treated patients: 13/27 responders (48%) achiev...

Descripción completa

Detalles Bibliográficos
Autores principales: Carpenedo, Monica, Cantoni, Silvia, Coccini, Veronica, Fedele, Marilena, Morra, Enrica, Pogliani, Enrico Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378205/
https://www.ncbi.nlm.nih.gov/pubmed/25852848
http://dx.doi.org/10.4081/hr.2015.5673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378205/
https://www.ncbi.nlm.nih.gov/pubmed/25852848
http://dx.doi.org/10.4081/hr.2015.5673

Ejemplares similares